Minke E. Rab
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.
Journal: American journal of hematology
Published: June 10, 2026
In-depth analysis of osmotic gradient ektacytometry parameters across different genotypes in hereditary spherocytosis.
Journal: British journal of haematology
Published: November 12, 2025
Cryopreservation of Red Blood Cells From Sickle Cell Disease Patients for Comparison of Oxygen Gradient Ektacytometry Parameters Between Laboratories to Enable Data Harmonization.
Journal: International journal of laboratory hematology
Published: October 29, 2025
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label study.
Journal: Haematologica
Published: September 02, 2025
Metabolomics in sickle cell disease: Current knowledge and gaps - A scoping review.
Journal: Blood reviews
Published: June 25, 2025
Iron Deficiency in HbSC Disease Treated With Repetitive Phlebotomy Is Associated With Fewer Sickle Cell Disease-Related Complications.
Journal: American journal of hematology
Published: March 25, 2025
Red blood cell pyruvate kinase properties in Townes and Berkeley sickle cell disease mouse models - Of mice and men.
Journal: Blood cells, molecules & diseases
Published: November 19, 2024
Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpura.
Journal: British journal of haematology
Published: October 09, 2024
Osmotic gradient ektacytometry - a novel diagnostic approach for neuroacanthocytosis syndromes.
Journal: Frontiers in neuroscience
Published: March 25, 2024
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.
Journal: HemaSphere
Published: January 30, 2024
Corrigendum to "Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme" [Blood Rev. 2023 Sep:61:101103].
Journal: Blood reviews
Published: December 03, 2023
Last Updated: 09/26/2026